Carboplatin and nab-paclitaxel chemotherapy with or without atezolizumab as front-line management for treatment-naïve metastatic nonsquamous non-small cell lung cancer with PD-L1 staining: a retrospective study

PURPOSE: The aim of this retrospective review was to compare the efficacy and safety of the atezolizumab plus carboplatin and nab-paclitaxel regimen versus the carboplatin and nab-paclitaxel regimen as front-line management for treatment-naïve, metastatic nonsquamous programmed death-ligand 1 (PD-L1...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Bo, Cheng, Huihui, Li, Kunhong, Lv, Yukai, Zeng, Xianshang, Liu, Tao, Yu, Weiguang, Guo, Wenbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article – Clinical Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508031/
https://www.ncbi.nlm.nih.gov/pubmed/34973080
http://dx.doi.org/10.1007/s00432-021-03873-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508031/
https://www.ncbi.nlm.nih.gov/pubmed/34973080
http://dx.doi.org/10.1007/s00432-021-03873-3

Ejemplares similares